These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1209 related articles for article (PubMed ID: 18619761)

  • 21. A population-based estimate of the extent of colorectal cancer screening in Ontario.
    Rabeneck L; Paszat LF
    Am J Gastroenterol; 2004 Jun; 99(6):1141-4. PubMed ID: 15180738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation of self-reported colorectal cancer screening behavior from a mixed-mode survey of veterans.
    Partin MR; Grill J; Noorbaloochi S; Powell AA; Burgess DJ; Vernon SW; Halek K; Griffin JM; van Ryn M; Fisher DA
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):768-76. PubMed ID: 18381474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surveillance behavior of women with a reported family history of colorectal cancer.
    Clavel-Chapelon F; Joseph R; Goulard H
    Prev Med; 1999 Feb; 28(2):174-8. PubMed ID: 10048109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Colorectal cancer test use from the 2005 National Health Interview Survey.
    Shapiro JA; Seeff LC; Thompson TD; Nadel MR; Klabunde CN; Vernon SW
    Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1623-30. PubMed ID: 18628413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of colorectal cancer tests--United States, 2002, 2004, and 2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Mar; 57(10):253-8. PubMed ID: 18340331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Barriers to colorectal cancer screening among Medicare consumers.
    Klabunde CN; Schenck AP; Davis WW
    Am J Prev Med; 2006 Apr; 30(4):313-9. PubMed ID: 16530618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colorectal cancer incidence in the United States, 1999-2004 : an updated analysis of data from the National Program of Cancer Registries and the Surveillance, Epidemiology, and End Results Program.
    Rim SH; Seeff L; Ahmed F; King JB; Coughlin SS
    Cancer; 2009 May; 115(9):1967-76. PubMed ID: 19235249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
    Tsoi KK; Ng SS; Leung MC; Sung JJ
    Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The public prefers fecal occult blood test over colonoscopy for colorectal cancer screening.
    Almog R; Ezra G; Lavi I; Rennert G; Hagoel L
    Eur J Cancer Prev; 2008 Oct; 17(5):430-7. PubMed ID: 18714185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
    Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
    J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Racial and ethnic disparities in colorectal cancer screening persisted despite expansion of Medicare's screening reimbursement.
    White A; Vernon SW; Franzini L; Du XL
    Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):811-7. PubMed ID: 21546366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Persistent demographic differences in colorectal cancer screening utilization despite Medicare reimbursement.
    Ko CW; Kreuter W; Baldwin LM
    BMC Gastroenterol; 2005 Mar; 5():10. PubMed ID: 15755323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measuring the quality of colorectal cancer screening: the importance of follow-up.
    Etzioni DA; Yano EM; Rubenstein LV; Lee ML; Ko CY; Brook RH; Parkerton PH; Asch SM
    Dis Colon Rectum; 2006 Jul; 49(7):1002-10. PubMed ID: 16673056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A population-based, community estimate of total colon examination: the impact on compliance with screening for colorectal cancer.
    Schoen RE; Weissfeld JL; Trauth JM; Ling BS; Hayran M
    Am J Gastroenterol; 2002 Feb; 97(2):446-51. PubMed ID: 11866286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of colonoscopy for colorectal cancer screening: evidence from the 2000 National Health Interview Survey.
    Subramanian S; Amonkar MM; Hunt TL
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):409-16. PubMed ID: 15734966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Receipt of colorectal testing prior to colorectal carcinoma diagnosis.
    Cooper GS; Payes JD
    Cancer; 2005 Feb; 103(4):696-701. PubMed ID: 15643638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Colorectal cancer screening among Mexican Americans at a community clinic.
    Yepes-Rios M; Reimann JO; Talavera AC; Ruiz de Esparza A; Talavera GA
    Am J Prev Med; 2006 Mar; 30(3):204-10. PubMed ID: 16476635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Colorectal carcinoma screening procedure use among primary care patients.
    Lafata JE; Williams LK; Ben-Menachem T; Moon C; Divine G
    Cancer; 2005 Oct; 104(7):1356-61. PubMed ID: 16092119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of self-reported history of colorectal cancer screening.
    Khoja S; McGregor SE; Hilsden RJ
    Can Fam Physician; 2007 Jul; 53(7):1192-7. PubMed ID: 17872816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased odds of interval left-sided colorectal cancer after flexible sigmoidoscopy compared with colonoscopy in older patients in the United States: a population-based analysis of the SEER-Medicare linked database, 2001-2005.
    Wang YR; Cangemi JR; Loftus EV; Picco MF
    Mayo Clin Proc; 2013 May; 88(5):471-8. PubMed ID: 23562347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 61.